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Regardless of the anatomic site that is infected, Gc promotes an 
inflammatory response that is characterized by the recruitment of 
PMNs (Figure 1). In men, PMNs appear in urethral swabs and urine 
several days after infection and immediately prior to the onset of 
symptoms (Cohen and Cannon, 1999). The purulent exudate pro-
duced by infected men, described in the Bible and by Galen, is the 
best-known aspect of gonorrheal disease and is reflected in the trans-
lation of “gonorrhea” from Greek as “flow of seed” (Edwards and 
Apicella, 2004). The cervical secretions of women with gonorrhea 
also contain PMNs (Evans, 1977). Bacteria in gonorrheal secretions 
are attached to and within PMNs (Ovcinnikov and Delektorskij, 
1971; Farzadegan and Roth, 1975; Evans, 1977; King et al., 1978; 
Apicella et al., 1996). PMNs are the primary innate immune respond-
ers to bacterial and fungal infection and are capable of phagocytos-
ing and killing a variety of microorganisms (Borregaard, 2010). Yet 
in spite of the numerous PMNs at the site of gonorrheal infection, 
viable Gc can be cultured from the exudates of infected individuals 
(Wiesner and Thompson, 1980), and a subset of Gc remain viable 
when Gc are exposed to PMNs in vitro (see below). We interpret 
these results to show that the PMN-driven innate immune response 
to Gc is ineffective at clearing a gonorrheal infection. The persistence 
of Gc in the presence of PMNs facilitates Gc’s long-term coloniza-
tion of its obligate human hosts, creating enhanced opportunity 
for dissemination and transmission of gonorrhea. In this review we 
will highlight our current knowledge about Gc resistance to PMN 
clearance, a critical aspect of the virulence of Gc.
Gonorrheal Disease
Gonorrhea is a major global health problem, with greater than 62 
million cases estimated to occur worldwide per year (Anonymous, 
2001). Numbers of reported cases in the United States have remained 
at approximately 330,000 annually, but it is estimated that the actual 
number is at least twice as high, and rates of gonorrhea are rapidly 
increasing among men who have sex with men and young adults 
(Workowski and Berman, 2010). The cause of gonorrhea is the Gram-
negative diplococcus Neisseria gonorrhoeae (the gonococcus or Gc). 
Gc is a human-specific pathogen that is transmitted via close sexual 
contact with an infected individual. Gonorrhea presents as an acute 
urethritis in men and cervicitis in women, but the pharynx and rec-
tum can also be infected (Wiesner and Thompson, 1980). Because 
of the frequently asymptomatic nature of female infection, gonor-
rhea is a major cause of pelvic inflammatory disease, characterized 
by abdominal pain and tubal scarring that results in ectopic preg-
nancy and infertility; untreated infections in men also lead to sterility. 
Disseminated Gc infections can cause arthritis–dermatitis syndrome, 
endocarditis, and meningitis. Gc can also be vertically transmitted 
during childbirth and is still a leading cause of infectious neonatal 
blindness in the developing world (Wiesner and Thompson, 1980). 
Gc remains a major public health problem due to rapid acquisition 
of resistance to multiple antibiotics (Tapsall, 2009) and its ability 
to phase and antigenically vary its surface structures, preventing 
infected individuals from developing a protective immune response 
and hindering development of a protective vaccine (Virji, 2009).
Resistance of Neisseria gonorrhoeae to neutrophils
M. Brittany Johnson and Alison K. Criss*
Department of Microbiology, University of Virginia, Charlottesville, VA, USA
Infection with the human-specific bacterial pathogen Neisseria gonorrhoeae triggers a potent, 
local inflammatory response driven by polymorphonuclear leukocytes (neutrophils or PMNs). 
PMNs are terminally differentiated phagocytic cells that are a vital component of the host 
innate immune response and are the first responders to bacterial and fungal infections. PMNs 
possess a diverse arsenal of components to combat microorganisms, including the production 
of reactive oxygen species and release of degradative enzymes and antimicrobial peptides. 
Despite numerous PMNs at the site of gonococcal infection, N. gonorrhoeae can be cultured 
from the PMN-rich exudates of individuals with acute gonorrhea, indicating that some bacteria 
resist killing by neutrophils. The contribution of PMNs to gonorrheal pathogenesis has been 
modeled in vivo by human male urethral challenge and murine female genital inoculation 
and in vitro using isolated primary PMNs or PMN-derived cell lines. These systems reveal 
that some gonococci survive and replicate within PMNs and suggest that gonococci defend 
themselves against PMNs in two ways: they express virulence factors that defend against 
PMNs’ oxidative and non-oxidative antimicrobial components, and they modulate the ability 
of PMNs to phagocytose gonococci and to release antimicrobial components. In this review, 
we will highlight the varied and complementary approaches used by N. gonorrhoeae to resist 
clearance by human PMNs, with an emphasis on gonococcal gene products that modulate 
bacterial-PMN interactions. Understanding how some gonococci survive exposure to PMNs 
will help guide future initiatives for combating gonorrheal disease.
Keywords: Neisseria gonorrhoeae, virulence factors, neutrophils, polymorphonuclear leukocytes, phagocytosis, reactive 
oxygen species, antimicrobial peptides, neutrophil proteases
Edited by:
Cynthia N. Cornelissen, Virginia 
Commonwealth University School of 
Medicine, USA
Reviewed by:
William Shafer, Emory University 
School of Medicine, USA
Rick Rest, Drexel University College of 
Medicine, USA
*Correspondence:
Alison K. Criss, Department of 
Microbiology, University of Virginia 
Health Sciences Center, Box 800734, 
Charlottesville, VA 22908-0734, USA. 
e-mail: akc2r@virginia.edu
www.frontiersin.org  April 2011  | Volume 2  | Article 77  |  1
Review ARticle
published: 13 April 2011
doi: 10.3389/fmicb.2011.00077PMn antiMicrobial activities
PMNs are the most abundant white cells in the peripheral blood 
of humans. They are professional phagocytes and the first line 
of defense of the innate immune system (Borregaard, 2010). In 
response to peripheral infection or damage, PMNs follow chem-
otactic  cues  to  extravasate  from  the  bloodstream  and  migrate 
through tissues to reach the target site. Mucosal epithelial cells and 
resident immune release chemokines for PMNs, including inter-
leukin-8, interleukin-6, tumor necrosis factor-α, and interleukin-1 
(Borregaard, 2010). These chemokines are released during human 
Gc infection (Ramsey et al., 1995; Hedges et al., 1998).
PMNs possess receptors to bind and phagocytose complement- 
and antibody-opsonized particles [e.g., complement receptor 3 (CR3), 
FcRs]. They can also engulf unopsonized particles through lectin-
like interactions or using receptors that are specific for ligands on 
the particle surface (Groves et al., 2008). Interaction between PMNs 
and a target particle results in the mobilization of different subsets 
of cytoplasmic granules to the plasma or phagosomal membrane 
(Figure 2). Granule fusion enables the degradation and killing of 
microorganisms both intracellularly and extracellularly (Borregaard 
et al., 2007). PMN mechanisms of microbial killing include pro-
duction of reactive oxygen species (ROS) via the NADPH oxidase 
enzyme (the “oxidative burst”) as well as the oxygen-independent 
activities of degradative enzymes and antimicrobial peptides (Table 
1). Human PMN granules are classified as azurophilic or primary 
granules, which contain myeloperoxidase, α-defensin peptides, and 
cathepsin G, among other antimicrobial components; specific or 
secondary granules containing the flavocytochrome b558 subunit of 
NADPH oxidase, LL-37 cathelicidin, lactoferrin, and CR3; and gela-
tinase or tertiary granules containing gelatinase (Borregaard et al., 
2007). PMN granules release their contents in a set order. Initially, 
gelatinase granule contents degrade extracellular matrix, allowing 
PMNs to migrate across the tissues underlying the site of infection. 
Next, the release of specific granules at the target destination increases 
phagocytic potential due to presentation of CR3 on the PMN surface. 
Finally, the release of both specific and azurophilic granules creates 
an environment that is generally hostile to microbial survival (Lacy 
and Eitzen, 2008). PMNs also release neutrophil extracellular traps 
(NETs) composed of DNA, histones, and selected granule compo-
nents, which trap and kill microbes without requiring phagocytosis 
(Papayannopoulos and Zychlinsky, 2009). Thus PMNs combine 
oxygen-dependent and -independent mechanisms to combat intra-
cellular and extracellular microorganisms.
The fact that gonorrheal exudates contain viable Gc indicates 
that PMNs are ineffective at completely clearing Gc infection. There 
are two mechanisms that could explain how Gc survives PMN 
challenge: Gc prevents PMNs from performing their normal anti-
microbial functions (phagocytosis, granule content release), or Gc 
expresses defenses against oxidative and non-oxidative components 
produced by PMNs (Figure 2). As we will discuss, there is now 
substantial evidence for both mechanisms, which ultimately enable 
Gc to survive within a host and be transmitted to new individuals.
MoDel systeMs For exaMininG PMns DurinG Gc 
PathoGenesis
Four experimental approaches have been used to investigate the 
involvement of PMNs in gonorrheal disease. Each has contributed 
to our understanding of how PMNs are recruited during acute 
gonorrhea and how Gc withstands this onslaught.
the Male urethral challenGe MoDel
Experimental human infection is limited to male urethral inocu-
lation, due to the potential for severe complications such as pel-
vic inflammatory disease in women with gonorrhea (Cohen and 
Figure 1 | gonorrhoeal exudates contain numerous PMNs with 
associated gc. Gram stain of the urethral exudate from a male with 
uncomplicated gonorrhea. Some PMNs associate with single diplococci (thin 
arrow), while others have multiple adherent and internalized Gc (thick arrow). 
Note that the majority of PMNs in the exudate are uninfected.
A
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Figure 2 | Cellular mechanisms of gc survival after exposure to PMNs. 
Gc (blue diplococcus) attaches to the surface of PMNs and is engulfed into a 
phagosome (white oval). PMNs possess three classes of granules (1°, 2°, and 
3°), each of which contains a unique subset of antimicrobial compounds. 
Granules fuse with the nascent phagosome or plasma membrane to deliver 
their contents to invading microorganisms. We propose two mechanisms that 
allow Gc to survive after exposure to PMNs. (For illustrative purposes, only 
intracellular Gc survival is depicted.) First, PMN granules release their 
contents at the plasma membrane or into phagosomes containing Gc (A). 
However, Gc virulence factors confer resistance to granules’ antimicrobial 
compounds. Second, Gc prevents PMN granules from releasing their 
contents at the plasma membrane or into phagosomes, allowing the bacteria 
to avoid encountering PMN antimicrobial compounds (B). Either mechanism 
would enable a fraction of Gc to survive and replicate in the presence of 
PMNs (C).
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akin to primary human PMNs (Bauer et al., 1999; Pantelic et al., 
2004). However, HL-60 cells do not possess the robust antimicrobial 
activity associated with primary cells, due in part to the absence of 
specific granules and other intracellular compartments (Le Cabec 
et al., 1997).
PriMary PMns
Research on the molecular mechanisms underlying Gc infection 
of PMNs has mostly relied upon primary human cells, purified 
from freshly isolated human blood. The abundance of PMNs in 
human blood and the ease of purification make PMNs amenable to 
infection with Gc in vitro. The limitations of working with primary 
PMNs include their short half-life, their limited capacity for genetic 
manipulation, and the person-to-person variability intrinsic to pri-
mary human cells. However, primary human PMNs have been used 
to measure binding and phagocytosis of Gc, quantify Gc survival 
after PMN exposure, and assess the roles of Gc virulence factors in 
bacterial defense against PMNs (see below). Gc infection of murine 
PMNs has also been conducted (Wu and Jerse, 2006; Soler-Garcia 
and Jerse, 2007). Future studies using primary PMNs along with 
cultured epithelial cells from relevant anatomic sites may provide 
a means to examine the complex interactions between host cells 
that occur during gonorrheal infection.
Gc interaction with PMNs is influenced by the physiological 
state of the PMNs being used. Initial experimentation with primary 
human PMNs utilized cells and Gc suspended in buffered saline 
solutions (Densen and Mandell, 1978; Rest et al., 1982), but this 
is unlikely to reflect the transmigrated, primed state of PMNs in 
the genitourinary tract during acute infection. Research from the 
laboratory of Dr. Richard Rest (Drexel University) demonstrated 
that when PMNs were allowed to adhere to tissue culture-treated 
dishes, they released granule components and bound significantly 
more Gc than PMNs in suspension (Farrell and Rest, 1990). Dr. 
Michael Apicella’s laboratory (University of Iowa) subsequently 
developed an assay using collagen-adherent PMNs, which gener-
ated a system for studying the role of selected Gc virulence factors 
in bacterial survival after PMN challenge (Seib et al., 2005; Simons 
et al., 2005). We adapted the Apicella protocol to include PMN 
treatment with the chemokine interleukin-8, which facilitates PMN 
activation (Borregaard, 2010). We used this system to demonstrate 
Gc survival inside PMNs and to identify Gc proteins that defend the 
bacteria from killing by PMNs (Stohl et al., 2005; Criss et al., 2009).
Gc survival anD rePlication in the Presence oF PMns
Although the survival of Gc in association with PMNs was once 
hotly debated, there is now substantial evidence that gonococci 
survive and multiply within human phagocytes. Examination of 
urethral exudates by light and electron microscopy has repeatedly 
shown the presence of abundant PMNs with associated and inter-
nalized Gc (Ovcinnikov and Delektorskij, 1971; Farzadegan and 
Roth, 1975; King et al., 1978; Apicella et al., 1996). The fact that 
viable gonococci can be cultured from urethral exudates or cervi-
cal swabs is strongly suggestive of Gc survival in the presence of 
PMNs (Wiesner and Thompson, 1980). In vitro studies from the 
Apicella laboratory using adherent human PMNs demonstrated 
that over 50% of Gc internalized by PMNs remained viable for 
Cannon, 1999). Urethral infection of male volunteers results in the 
release of proinflammatory cytokines and appearance of PMNs 
in the urogenital tract 2–3 days after infection, similar to what is 
seen in natural cases of gonococcal urethritis (Cohen and Cannon, 
1999). As in natural infections, exudates from males with experi-
mental Gc infection contain PMNs with associated Gc and occa-
sional exfoliated epithelial cells. Electron microscopic analysis of 
these exudates revealed that a subset of Gc inside PMNs appear 
intact, providing the initial evidence that Gc may survive within 
PMN phagosomes (Ovcinnikov and Delektorskij, 1971; Farzadegan 
and Roth, 1975; Apicella et al., 1996).
the FeMale Murine Genital tract MoDel
Dr.  Ann  Jerse  (Uniformed  Services  University  of  the  Health 
Sciences) has developed a female mouse model of Gc genital tract 
infection, which allows gonorrheal infection to be examined in a 
genetically tractable host. In this model, estradiol-treated mice are 
inoculated vaginally with Gc, which allows over 80% of mice to 
be colonized with bacteria for over 1 week. Infected mice produce 
inflammatory cytokines, leading to rapid appearance of PMNs in 
the genital tract (Jerse, 1999). Experimental infection of female 
mice has provided insight into the selective advantage of opacity-
associated (Opa) protein expression on Gc survival and the roles of 
Gc virulence factors conferring in vitro resistance to ROS and anti-
microbial peptides in in vivo infection (Jerse, 1999; Jerse et al., 2003; 
Wu and Jerse, 2006; Wu et al., 2009; Cole et al., 2010). Because mice 
lack the human-specific receptors and other components that are 
likely to be important for gonorrheal disease, future studies could 
employ mice transgenic for human proteins of interest. Inbred 
mice that are transgenic for human carcinoembryonic antigen-
related cellular adhesion molecules (CEACAMs) and CD46, recep-
tors that are implicated in gonorrheal pathogenesis (Merz and So, 
2000), have already been developed (Johansson et al., 2003; Gu 
et al., 2010), with additional mouse strains likely to be produced 
in the coming years.
iMMortalizeD PMn-like cell lines
The use of immortalized promyelocytic human cell lines to study 
the molecular mechanisms of Gc pathogenesis provides a system 
which is clonal, easy to maintain, and amenable to expression of 
transgenes. As one example, the leukemic HL-60 cell line can be dif-
ferentiated into a PMN-like phenotype with retinoic acid (Collins 
et al., 1977; Newburger et al., 1979). Differentiated HL-60 cells can 
Table 1 | Antimicrobial components housed in PMN granules.
granule class  granule components
Primary/azurophilic  Cathepsin G, BPI, lysozyme, elastase, 
  myeloperoxidase (MPO), α-defensins
Secondary/specific  Flavocytochrome b558, LL-37 (hCAP18), lysozyme, 
  gelatinase, lactoferrin, CD11b/CD18 (CR3)
Tertiary/gelatinase  Flavocytochrome b558, lysozyme, gelatinase, 
  CD11b/CD18 (CR3)
Proteins that have been shown to have or produce antimicrobial activity against 
Gc  in  vitro  are  bolded  and  italicized.  Proteins  to  which  Gc  is  resistant  are 
indicated in red type.
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immune system comprised of more than 30 proteins. The com-
plement system can be activated by three routes: the classical, the 
alternative, and the lectin pathway, but all three routes normally 
proceed to proteolytic activation of the major complement protein 
C3 and assembly of the membrane attack complex (Ram et al., 
2010). Gc has multiple ways of resisting the bactericidal activities 
of complement in normal human serum. Gc binds the comple-
ment regulatory proteins C4b-binding protein (C4BP) and factor 
H (fH) on its surface via porins and sialylated LOS (Ram et al., 
1998a,b, 2001; Gulati et al., 2005). C4BP restricts the amount of C3 
which can be deposited by the classical complement pathway. fH is 
a cofactor for factor I-mediated cleavage of C3b to the hemolytically 
inactive iC3b. In the alternative pathway fH irreversibly dissociates 
factor Bb to limit C3 deposition and subsequent C5 cleavage (Ram 
et al., 2010). C4BP and fH provide defense against direct comple-
ment-mediated killing but concomitantly increase iC3b deposi-
tion on the Gc surface. iC3b is a ligand for CR3 (CD11b/CD18), 
which in PMNs drives actin-dependent particle engulfment into 
degradative phagolysosomes and production of ROS (Groves et al., 
2008). Although it is assumed that Gc is complement-opsonized 
at mucosal surfaces, how opsonization impacts Gc survival after 
PMN exposure remains to be explored.
up to 6 h, as determined by viable bacterial counts and electron 
microscopy (Simons et al., 2005). Our group corroborated these 
findings and directly detected viable extracellular and intracellu-
lar Gc after PMN infection, using dyes that reveal the integrity of 
bacterial membranes (Criss et al., 2009). We conclude from these 
studies that a fraction of Gc can survive both extracellularly and 
intracellularly in the presence of PMNs.
There is evidence that Gc does not only persist within PMNs, 
but also uses the PMNs as a site for replication. Pioneering studies 
in the 1970s showed that Gc inside exudate-derived PMNs were 
sensitive to penicillin, which only kills replicating bacteria. In the 
presence of antimicrobial agents such as spectinomycin or pyocin 
that cannot permeate eukaryotic membranes, numbers of PMN-
associated Gc increased over time, indicative of bacterial replication 
inside exudatous and in vitro-infected PMNs (Veale et al., 1976, 
1979; Casey et al., 1979, 1980, 1986). Using electron microscopy 
and colony counts, the Apicella laboratory observed an increase 
in Gc within collagen-adherent human PMNs over a 6-h infec-
tion, results also suggestive of intracellular replication (Simons 
et al., 2005). Similarly, we used bacterial viability dyes to observe 
an increase in the number of viable Gc inside PMNs over time 
(Criss et al., 2009). While the advantage of Gc replicating inside 
terminally differentiated cells of a limited life span is questionable, 
the Apicella group showed that PMNs infected with Gc delay their 
spontaneous apoptosis (Simons et al., 2006). We anticipate that 
advances in cellular imaging will provide additional support for 
Gc replication inside PMNs and will give insight into the timing 
and extent of this event.
binDinG anD PhaGocytosis oF Gc by PMns
Since gonorrheal secretions contain PMNs associated with viable 
intracellular and extracellular bacteria, Gc must possess factors 
that promote attachment and phagocytosis by PMNs. Opsonic and 
non-opsonic interactions are the two basic means of phagocytosis, 
both of which may be utilized by Gc (Groves et al., 2008; Figure 3).
oPsonic uPtake
The two major opsonins for PMN phagocytosis are immunoglob-
ulins and complement, which bind to Fc receptors and comple-
ment receptors such as CR3, respectively (Groves et al., 2008). 
Patients with gonorrhea produce opsonic IgG and IgA directed 
against Gc surface-exposed components including porin, Opa 
proteins,  pilin,  iron-regulated  outer  membrane  proteins,  and 
lipooligosaccharide (LOS) (Brooks et al., 1976; McMillan et al., 
1979; Tramont et al., 1980; Rice and Kasper, 1982; Siegel et al., 
1982; Lammel et al., 1985; Schwalbe et al., 1985). Intriguingly, 
serum from individuals with no prior history of gonorrhea con-
tains opsonic IgG against Gc porin and IgM against Gc LOS iso-
types containing hexosamine; the non-Gc antigens recognized by 
these antibodies are not known (Sarafian et al., 1983; Griffiss et al., 
1991). Many of the Gc surface structures that promote humoral 
immune responses are phase and antigenically variable and thus 
evade antibody-mediated immune surveillance (Virji, 2009). Also, 
Gc secretes an IgA protease that cleaves the polymeric IgA in 
mucosal secretions (Blake and Swanson, 1978). Thus complement 
rather than antibodies is likely to drive the opsonic phagocytosis 
of Gc by PMNs.
A B C
Figure 3 | Opsonic and non-opsonic phagocytosis of gc by PMNs. (A) 
Antibodies that recognize Gc surface structures opsonize the bacteria and 
allow for phagocytosis via Fc receptors. The efficacy of immunoglobulin-
mediated phagocytosis is questionable given the extensive phase and 
antigenic variation of Gc surface structures. (B) Gc binds factor H and C4 
binding protein, resulting in opsonization of Gc with C3 and other complement 
components. Gc is then phagocytosed via the CR3 receptor. Gc pili and porin 
can cooperatively interact with CR3, which may mediate the non-opsonic 
phagocytosis of Gc by PMNs. (C) Selected Opa proteins bind to CEACAM 
family receptors expressed on PMNs, leading to non-opsonic phagocytosis of 
Opa+ Gc.
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Whether they remain extracellular or are phagocytosed by PMNs, 
Gc must contend with the variety of oxidative and non-oxidative 
antimicrobial components produced by PMNs (Figure 2). Gc iso-
lated directly from human material or guinea pig subcutaneous 
chamber fluid display increased survival in the presence of phago-
cytes compared to Gc grown in vitro (Witt et al., 1976; Veale et al., 
1977), suggesting that Gc possesses factors necessary for defending 
against phagocyte killing that are lost or altered with extended in 
vitro culture. These Gc factors aid Gc in resisting the toxic activities 
of PMNs in two ways. First, Gc prevents PMNs from producing or 
releasing antimicrobial components. Second, Gc expresses virulence 
factors that defend against these components. As we will describe, 
many Gc gene products have been identified that protect Gc from 
purified ROS, proteases, or antimicrobial peptides, but in most cases 
their roles in defense against PMNs have not yet been investigated.
DeFenses aGainst oxiDative DaMaGe
The major species of ROS include superoxide anion, hydrogen 
peroxide, and hydroxyl radical. These ROS have different reac-
tivities and half-lives, but together they induce DNA, protein, and 
cell membrane damage that can lead to cell death (Fang, 2004). 
There are at least four potential sources of oxidative stress for Gc 
in vivo. (1) PMN NADPH oxidase transports electrons across the 
phagosomal or plasma membrane to generate superoxide, which 
spontaneously dismutates to hydrogen peroxide. In PMNs, the 
azurophilic enzyme myeloperoxidase uses hydrogen peroxide as a 
substrate to generate hypochlorous acid (bleach; Roos et al., 2003). 
Phagocytes can also produce reactive nitrogen species (RNS) such 
as nitric oxide and peroxynitrite, but RNS appear to be of limited 
importance in human PMN antimicrobial activity (Fang, 2004). 
(2) Enzymes related to phagocyte NADPH oxidase are expressed in 
epithelial cells, and the survival defect of Gc antioxidant mutants 
inside primary cervical cells implies that epithelial cells may also be 
an important source of oxidative stress for Gc (Wu et al., 2005, 2006; 
Achard et al., 2009; Potter et al., 2009). (3) Lactobacillus species 
that generate hydrogen peroxide are normally found in the vaginal 
flora of women (Eschenbach et al., 1989). Women with inhibi-
tory lactobacilli are less likely to be infected with Gc (Saigh et al., 
1978), and lactobacilli inhibit Gc growth in vitro (Saigh et al., 1978; 
Zheng et al., 1994; St Amant et al., 2002). However, it appears that 
effects of lactobacilli on Gc may be independent of hydrogen per-
oxide production, since mucosal secretions can effectively quench 
lactobacilli-derived ROS (O’Hanlon et al., 2010). (4) Gc generate 
ROS during aerobic respiration, although this may be less of an 
issue in vivo, where the oxygen tension in the genitourinary tract 
is low (Archibald and Duong, 1986). Gc defenses against oxidative 
stress involve manipulation of the PMN oxidative burst, detoxifying 
or repair of oxidative damage, and transcriptional upregulation of 
antioxidant gene products (Figure 4A).
Gc manipulation of the PMN oxidative burst
In the absence of Opa protein expression, Gc fails to induce the PMN 
oxidative burst (Rest et al., 1982; Virji and Heckels, 1986; Fischer and 
Rest, 1988; Criss and Seifert, 2008). Even in the presence of Opa+ 
Gc that induce ROS production in PMNs, the magnitude of ROS 
production is small relative to stimuli such as phorbol esters or other 
non-oPsonic uPtake
In the absence of antibodies or complement, efficient binding and 
engulfment of Gc by PMNs is achieved via expression of colony 
Opa proteins (King and Swanson, 1978; Virji and Heckels, 1986; 
Fischer and Rest, 1988). Opa proteins, formerly known as “pro-
tein II,” are a family of closely related, 20–30 kD outer membrane 
proteins that facilitate Gc binding and internalization by human 
cells, including PMNs (Sadarangani et al., 2011). Gc strains possess 
approximately 11 opa genes encoding 7–8 antigenically distinct 
Opa proteins (Connell et al., 1990; Dempsey et al., 1991). Each opa 
gene is phase-variable due to slipped-strand mispairing in a pen-
tameric nucleotide repeat that places the gene in our out of frame 
(Murphy et al., 1989), such that individual Gc can express zero, one, 
or any possible combination of Opa proteins. Differential expres-
sion of Opa proteins can influence bacterial tropism for host cell 
types and provides a mechanism of immune evasion (Sadarangani 
et al., 2011).
Opacity-associated proteins bind heparan sulfate proteogly-
cans (HSPGs) and/or CEACAMs. Only those Opa proteins that 
bind CEACAMs are reported to influence Gc interactions with 
PMNs (Sadarangani et al., 2011). The Opa-binding CEACAMs 
on  PMNs  are  CEACAM1,  CEACAM3,  and  CEACAM6,  with 
CEACAM3 expression exclusively restricted to PMNs. CEACAM1 
and CEACAM3 are transmembrane proteins, while CEACAM6 
possesses a glycosylphosphatidylinositol anchor (Gray-Owen and 
Blumberg, 2006). Binding of Opa proteins to any of the three 
CEACAMs results in Gc internalization, but via different signal-
ing events (McCaw et al., 2004).
Opacity-associated protein expression is selected for in the male 
urethra, the female cervix during the follicular phase of the men-
strual cycle, and in the murine cervix (James and Swanson, 1978; 
Swanson et al., 1988; Jerse et al., 1994; Jerse, 1999). However, Opa− 
Gc survives better after exposure to PMNs in vitro than isogenic 
Opa+ Gc (Rest et al., 1982; Virji and Heckels, 1986; Criss et al., 2009). 
Opa protein expression increases Gc phagocytosis by PMNs and 
stimulates PMN ROS production, and both factors may influence 
bacterial survival after exposure to PMNs (Rest et al., 1982; Fischer 
and Rest, 1988).
Gc surface structures other than Opa proteins may contribute to 
adherence and phagocytosis by PMNs. Pili and porin cooperatively 
interact with CR3 on cervical epithelial cells (Edwards et al., 2002). 
It is not known if this interaction occurs on PMNs, but if it were to 
occur, it would drive non-opsonic uptake of Gc by PMNs. In vitro 
studies suggested that “type 1,” virulent, piliated Gc were resistant to 
phagocytosis and killing by PMNs compared to “type 4,” avirulent, 
non-piliated bacteria that arise after extensive laboratory passage 
(Ofek et al., 1974; Dilworth et al., 1975). We now know that type 
1 and type 4 Gc vary in Opa expression as well as piliation, both 
of which could have contributed to these observations. Purified 
porins also decrease PMN actin polymerization, which may reduce 
the phagocytosis of Gc by PMNs (Bjerknes et al., 1995). Serogroup 
C strains of N. meningitidis with lacto-N-neotetraose (LNnT) on 
LOS are phagocytosed by neutrophils in an opsonin-independent 
manner (Estabrook et al., 1998); it has not been examined whether 
this LOS epitope on Gc affects phagocytosis by PMNs. Together, 
the combinatorial expression of Opa proteins, pili, porin, and LOS 
modulate Gc binding and internalization by PMNs.
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et al., 2001). In comparison, KatA is crucial to Gc defense against 
ROS. Gc has approximately 100-fold higher levels of catalase than E. 
coli (Hassett et al., 1990). Disruption of katA significantly reduces Gc 
survival to hydrogen peroxide and superoxide in vitro (Johnson et al., 
1993; Soler-Garcia and Jerse, 2004; Stohl et al., 2005) and reduces 
the survival of some strains of Gc in the female murine genital tract 
(Wu et al., 2009). Gc also has high peroxidase Gc activity due to the 
periplasmic cytochrome c peroxidase encoded by ccp (Archibald and 
Duong, 1986). ccp mutant Gc show slight sensitivity to hydrogen 
peroxide, which is markedly enhanced when katA is also inactivated 
(Turner et al., 2003). Gc also imports Mn(II) into its cytoplasm via the 
MntABC transporter, where it scavenges superoxide and hydrogen 
peroxide by a mechanism independent of SodB and catalase (Tseng 
et al., 2001). This system is similar to the manganese transport system 
in Lactobacillus plantarum (Archibald and Duong, 1984).
Gc can also repair oxidative damage to proteins and DNA. Gc 
expresses two forms of methionine sulfoxide reductase, which reverses 
the oxidation of methionine residues in proteins. The MsrA pro-
tein is localized to the cytoplasm, while MsrB is secreted to the outer 
membrane. A msrAB mutant is more sensitive to hydrogen peroxide 
and superoxide in vitro than its wild-type parent (Skaar et al., 2002). 
bacteria (Simons et al., 2005). Gc utilizes three mechanisms to reduce 
the amount of ROS produced by PMNs. First, exposure to lactate that 
is released from PMNs undergoing glycolysis stimulates the rate of 
Gc oxygen consumption, reducing the amount available to PMNs as 
a substrate for NADPH oxidase (Britigan et al., 1988). Second, puri-
fied Gc porin inhibits PMN ROS production in response to Gc, yeast 
particles, and latex beads (Lorenzen et al., 2000), but not formylated 
peptides (Haines et al., 1988; Bjerknes et al., 1995). Whether porin has 
this effect in the context of whole Gc bacteria remains to be examined. 
Third, we reported that Opa− Gc suppresses the PMN oxidative burst 
induced by serum opsonized staphylococci and formylated peptides 
by a process requiring bacterial protein synthesis and bacteria-PMN 
contact; the bacterial products mediating this effect are not known 
at this time (Criss and Seifert, 2008).
Detoxification and repair of oxidative damage
Bacteria respond to oxidative stress by catalysis of superoxide to 
hydrogen peroxide by superoxide dismutase (SOD), which is then 
converted to water and molecular oxygen by catalases and peroxi-
dases (Seib et al., 2006). Gc possesses a single cytoplasmic superoxide 
dismutase (SodB), one cytoplasmic catalase (KatA), and several genes 
annotated as peroxidases. SodB activity is low in Gc and does not 
A B
Figure 4 | Mechanisms of gc survival after exposure to antimicrobial 
compounds produced by PMNs. (A) Resistance to oxidative damage. PMN 
NADPH oxidase generates superoxide (O2
−) and hydrogen peroxide (H2O2) from 
O2, which are converted to hypochlorous acid (HOCl) by myeloperoxidase 
(MPO). Gc prevents PMNs from generating ROS by lactate-mediated increase in 
Gc O2 consumption and suppression of NADPH oxidase activity by porin or 
as-yet unidentified factors. Gc scavenges ROS through the activities of MntABC, 
superoxide dismutase (SodB), catalase (KatA), and cytochrome c peroxidase 
(Ccp). Gc can also repair damage due to ROS through DNA repair enzymes 
(RecN), protein reductases (MsrA/B), and other proteins (Ngo1686). (B) 
Resistance to PMN non-oxidative damage. Gc pili and/or porins prevent PMN 
granules from releasing non-oxidative antimicrobial components. LOS protects 
Gc outer membrane proteins such as Opa and porin from proteolysis by 
cathepsin G. Sialylation of LOS by Lst and PEA modification of LOS by LptA 
increases bacterial resistance to cathepsin G and other antimicrobials. The MisR/
MisS two-component regulator increases expression of LptA and other gene 
products that confer resistance to PMN non-oxidative damage. Ngo1686 and 
RecN also protect Gc from PMN non-oxidative damage. The MtrCDE and FarAB 
efflux pumps export cationic antimicrobial peptides (CAMPs) and long-chain fatty 
acids (FA) from the Gc cytoplasm, respectively. In most cases, the contribution 
of these virulence factors to Gc survival after exposure to PMNs remains to be 
determined.
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and LL-37 antimicrobial peptide (Casey et al., 1985; Shafer et al., 
1986, 1998). Unlike many Gram-negative bacteria, Gc are highly 
resistant (>0.2 mg/ml) to another class of antimicrobial peptides, 
the defensins (Qu et al., 1996), although the observed resistance 
varies depending on experimental conditions used (Porter et al., 
2005). Of PMN non-oxidative granule components, cathepsin G 
and LL-37 have been the most actively studied for their effects on Gc.
Cathepsin G is a highly cationic serine protease which resides 
in PMN azurophilic granules. It enzymatically cleaves Gc outer 
membrane proteins including porin and Opa proteins (Rest and 
Pretzer, 1981; Shafer and Morse, 1987). However, heat and protease 
inhibitors do not impede cathepsin G’s ability to kill Gc in vitro, 
indicating its antigonococcal activity is independent of its proteo-
lytic activity (Shafer et al., 1986). Cathepsin G can insert into Gc 
membranes, but killing does not appear to be due to changes in 
membrane permeability; instead, cathepsin G may impede pepti-
doglycan biosynthesis (Shafer et al., 1990).
LL-37  is  the  active  form  of  an  18  kD  protein  precursor 
(“hCAP18”) which resides in specific granules. hCAP-18 is proteo-
lytically processed to LL-37 by the azurophilic granule protein pro-
teinase-3 (Sorensen et al., 2001). hCAP-18/LL-37 is also synthesized 
by mucosal epithelial cells, and is readily detected in cervicovaginal 
secretions (mean LL-37 concentration of 10 μg/ml) and seminal 
plasma (mean hCAP-18 concentration of 86 μg/ml; Malm et al., 
2000; Tjabringa et al., 2005). Gc infection increases the levels of 
hCAP18/LL-37 by two- to four-fold in cervical and urethral washes 
(Porter et al., 2005; Tjabringa et al., 2005). These concentrations of 
LL-37 would be sufficient to exert antibacterial activity on Gc, since 
the mean inhibitory concentration of LL-37 for Gc is 6 μg/ml (Shafer 
et al., 1998). The antigonococcal mechanism of action of LL-37 
remains enigmatic and may be related to its ability to form pores 
that disrupt the integrity of bacterial membranes (Brogden, 2005).
Although Gc are susceptible to cathepsin G and LL-37 in vitro, 
the ability of some percentage of Gc to survive PMN exposure 
suggests that the bacteria have evolved mechanisms to counter 
these antimicrobial components. These mechanisms involve direct 
modulation of PMN granule release, changes to the Gc surface to 
resist non-oxidative antimicrobial components, and active export 
of these components (Figure 4B).
Modulation of PMN granule release
Both pili and porin have been reported to reduce PMN granule 
fusion with the plasma membrane or phagosomes. When added 
to primary PMNs, purified porins inhibit azurophilic and specific 
granule exocytosis (Bjerknes et al., 1995; Lorenzen et al., 2000). 
“Type 1,” piliated Gc was also reported to inhibit azurophilic gran-
ule exocytosis relative to “type 4,” non-piliated Gc, but additional 
surface structures expressed on type 1 bacteria may have mediated 
this result (Densen and Mandell, 1978). More detailed studies with 
isogenic Gc strains are necessary to determine whether and how 
Gc surface structures influence granule mobilization.
Modifications to the Gc surface
Gc LOS is thought to mask proteins which are degraded by cathe-
psin G, since truncation or loss of LOS results in increased binding 
of cathepsin G and increased susceptibility to cathepsin G-mediated 
Many Gc gene products involved in recombinational DNA repair, 
base excision repair, and nucleotide excision repair participate in Gc 
defense against ROS, such as the recombinase RecA and the DNA-
binding protein RecN (Davidsen et al., 2005; Stohl et al., 2005; Stohl 
and Seifert, 2006; LeCuyer et al., 2010). The putative metallopro-
tease Ngo1686 helps protect Gc from hydrogen peroxide and the 
lipid oxidant cumene hydroperoxide, but the cellular targets with 
which Ngo1686 interacts are currently unknown (Stohl et al., 2005). 
Both ngo1686 and recN mutants have significant survival defects after 
exposure to primary human PMNs, but a recA mutant does not (Stohl 
et al., 2005; Criss et al., 2009).
Transcriptional induction of antioxidant gene products
Gc pre-exposed to hydrogen peroxide survives PMN challenge 
significantly better than unexposed Gc (Criss et al., 2009). This 
finding implies that Gc possesses complex transcriptional cir-
cuitry that is important for defenses against ROS and/or PMNs. 
The transcriptome of Gc exposed to sublethal concentrations of 
hydrogen peroxide was defined and revealed the upregulation of 
transcripts encoding RecN, Ngo1686, and other antioxidants after 
oxidative challenge (Stohl et al., 2005). Antioxidant gene expres-
sion is regulated by selected transcriptional repressors. The OxyR 
protein represses KatA expression, which is relieved following oxi-
dative stress in order to increase catalase production (Tseng et al., 
2003). PerR is responsive to Mn(II) levels and represses expression 
of MntC, part of the Mn(II) transporter (Wu et al., 2006). Finally, 
Ngo1427, a LexA homolog, represses expression of RecN, which is 
relieved when a cysteine residue is oxidized (Schook et al., 2011).
PMns PriMarily Direct non-oxiDative antiMicrobial 
coMPonents aGainst Gc
Although Gc has complex mechanisms for detecting oxidative damage 
and responding to it, the importance of these processes in Gc survival 
to PMNs appears to be limited. Mutants in katA, sodB, ccp, or mntABC, 
alone or in combination, do not affect the percentage of Gc that can 
survive PMN challenge (Seib et al., 2005; Criss et al., 2009). Moreover, 
Gc survival is similar between normal PMNs and ROS-deficient PMNs 
obtained from patients with chronic granulomatous disease (CGD; 
Rest et al., 1982; Criss and Seifert, 2008), and PMNs maintained in 
anoxic conditions, as are likely to be found in the upper reproductive 
tract of females, are not impaired for antigonococcal activity (Casey 
et al., 1986; Frangipane and Rest, 1992). Our group showed that Gc 
survival was unaffected after exposure to PMNs treated with diphenyle-
neiodonium (DPI), an inhibitor of NADPH oxidase. DPI treatment or 
CGD PMNs did not increase the percent survival of ngo1686 or recN 
Gc, nor did it enhance survival of Opa+ Gc that induce ROS from 
PMNs (Criss et al., 2009). From these results, we conclude that PMNs 
primarily direct non-oxidative antimicrobial activities against Gc. The 
functional redundancy in Gc antioxidant defenses may be sufficient 
to counter PMN-derived ROS; alternatively, PMNs may not generate 
enough ROS during infection to affect Gc survival.
DeFenses aGainst non-oxiDative DaMaGe
Seminal research from the Rest and Shafer laboratories indicated 
that  components  found  inside  PMN  granules  display  oxygen-
independent antigonococcal activity (Rest, 1979; Casey et al., 1985; 
Rock and Rest, 1988). These components include the bactericidal/
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sion is believed to be important for survival of isolates at the rectal 
mucosal surface, which is rich in diet-derived fatty acids, and does 
not contribute to Gc survival in the murine genital tract (Jerse et al., 
2003). How the Far system contributes to defense of Gc against 
PMNs, which may release fatty acids (Huang et al., 2010), remains 
to be explored.
Discussion
Despite the prevalence of gonorrhea in the human population 
and the abundance of PMNs during acute gonorrheal disease, 
we are just beginning to understand the molecular mechanisms 
underlying Gc interactions with and resistance to PMNs. There are 
three overarching questions which remain currently in the field. 
First, how does a subset of Gc survive PMN challenge? As we have 
described, Gc possesses gene products which protect against oxida-
tive and non-oxidative components that are made by PMNs. Many 
of these gene products are necessary for in vitro protection against 
isolated antimicrobial components and some provide a selective 
advantage in vivo. However, in many cases, it has not been investi-
gated whether these gene products also confer a survival advantage 
in the context of PMN challenge. Second, how does Gc persist over 
time inside PMNs, as is seen in PMNs isolated from gonorrheal exu-
dates? Although virulence-associated Gc surface structures such as 
Opa proteins, pili, porin, and LOS have been highly investigated for 
their biochemistry and impact on Gc-epithelial interactions, their 
effects on Gc survival inside PMNs remain enigmatic. How comple-
ment or immunoglobulin opsonization affects Gc phagocytosis by 
and survival inside PMNs also needs to be examined. Finally, how 
and why does Gc stimulate PMN recruitment? That is, what is the 
benefit of recruiting professional antimicrobial cells to the site of Gc 
infection? Given the long history of Gc in the human population, 
Gc could have evolved mechanisms for inhibiting PMN recruit-
ment; instead, Gc LOS and lipoproteins are strong initiators of the 
host innate immune response (Massari et al., 2002; Pridmore et al., 
2003; Zughaier et al., 2004). The answer to this question remains 
enigmatic, but may be revealed once we have a better understanding 
of how Gc manipulates PMNs in vitro and in vivo.
Our current knowledge of Gc interactions with PMNs dem-
onstrates the impressive ability of Gc to survive PMN challenge. 
Although we are just beginning to piece together the roles of many 
Gc surface structures and gene products in Gc survival after PMN 
exposure, we now have model systems in hand that will allow these 
issues to be directly addressed. We are optimistic that continuing to 
investigate the mechanisms used by Gc to defend against PMN anti-
microbial responses will shed light on how Gc has remained a fixture 
in the human population for all of recorded history (Wain, 1947; 
Morton, 1977). This research also has the potential to reveal novel 
human and Gc targets that can be exploited for new therapeutics to 
treat the ever-growing threat of highly antibiotic-resistant gonorrhea.
acknowleDGMents
We thank Dr. Jeffrey Tessier for obtaining the clinical sample for 
the image in Figure 1. We thank Louise Ball, Joanna Goldberg, and 
the two reviewers for helpful comments on the manuscript. This 
work was supported in part by NIH R00 TW008042 (Alison K. 
Criss) and T32 AI007046 (M. Brittany Johnson).
killing (Shafer, 1988). Two modifications of LOS impact bacte-
rial interactions with host cells and host defenses: phosphoeth-
anolamine (PEA) substitution on lipid A or the oligosaccharide, and 
sialylation of the terminal Galβ1-4GlcNAc epitopes of the oligosac-
charide (Mandrell et al., 1990; Plested et al., 1999). PEA addition 
to the heptose group on the beta chain of the core oligosaccharide 
enhances Gc serum resistance but does not affect susceptibility to 
antimicrobial peptides (Lewis et al., 2009). In contrast, PEA addi-
tion to lipid A by the LptA enzyme increases resistance to both 
normal human serum and cationic antimicrobial peptides¸ indi-
cating that structural changes in LOS contribute to the ability of 
gonococci to resist the bactericidal action of these innate immune 
components (Lewis et al., 2009). In the related bacterium N. men-
ingitidis, expression of lptA is positively regulated by the misR/misS 
two-component regulatory system (Newcombe et al., 2005; Tzeng 
et al., 2008). The roles of MisR/MisS and LptA in Gc pathogenesis 
remain to be examined. The gonococcal α-2,3-sialyltransferase Lst 
transfers sialyl groups from host-derived CMP-N-acetylneuraminic 
acid to the terminal galactose residue on the oligosaccharide of LOS 
(Gilbert et al., 1996). Sialylation contributes to Gc resistance to 
normal human serum as well as PMN-derived oxygen-independ-
ent antimicrobial factors (Shafer et al., 1986; Parsons et al., 1992). 
Importantly, sialylated Gc are more resistant to PMNs in vitro, and 
sialylation contributes to Gc survival in the murine female genital 
tract (Kim et al., 1992; Rest and Frangipane, 1992; Gill et al., 1996; 
Wu and Jerse, 2006). In addition to LOS, changes in other surface 
components may contribute to Gc resistance to non-oxidative anti-
microbial factors. For instance, loss of Opa expression enhances Gc 
resistance to serine proteases (Blake et al., 1981; Cole et al., 2010), 
and N. meningitidis lacking pili (due to insertional mutagenesis of 
the pilMNOPQ operon) are more resistant to the model antimi-
crobial peptide polymyxin B (Tzeng et al., 2005).
Gc export of antimicrobial components
The multiple transferable resistance (mtr) locus is a key deter-
minant of Gc resistance to antimicrobial agents (Shafer et al., 
1998). Mtr, a member of the resistance-nodulation-cell division 
(RND) family of efflux pumps, is encoded by a three gene operon 
designated mtrCDE. MtrC spans the periplasm to link the inner 
membrane protein MtrD, the multidrug efflux transporter, with 
outer membrane protein MtrE, the channel for export of antimi-
crobials to the extracellular environment (Hagman et al., 1995). 
MtrCDE uses the proton motive force to export a variety of com-
pounds from the Gc cytoplasm, including antibiotics, detergents, 
and antimicrobial peptides (Hagman et al., 1995; Veal et al., 2002). 
mtrCDE is negatively regulated by the MtrR transcriptional repres-
sor (Hagman and Shafer, 1995) and positively regulated by the 
MtrA transcriptional activator (Rouquette et al., 1999). Mutations 
in mtrR and mtrA that modulate expression of MtrCDE affect Gc 
resistance to antimicrobial peptides (Hagman et al., 1995; Hagman 
and Shafer, 1995). MtrCDE expression promotes Gc survival in the 
murine female genital tract (Jerse et al., 2003) and enhances resist-
ance to murine antimicrobial peptides (Warner et al., 2008), but 
its role in defense of Gc against PMNs is unclear. Gc also uses the 
FarAB efflux pump system to confer resistance to long-chain fatty 
acids, independent of Mtr activity (Lee and Shafer, 1999). The Far 
system is composed of the FarA membrane-spanning linker, the 
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